Eugenics and the Human/Animal Divide in Guardians of the Galaxy Vol. 3
By Leigha McReynolds,
Tor
| 09. 19. 2023
The 2011 X-Men franchise prequel, X-Men: First Class, briefly featured a mutant named Darwin who could adapt to any circumstances. For example, when he stuck his head in a fish tank he grew gills. Now if you’re a history of science nerd like me, you both appreciate the Darwinian reference and wish that the movie had instead named the character Lamarck, who theorized that individual animals could adapt to environments and experience physical changes during their lives—but that doesn’t have quite the same ring to it. Darwin, on the other hand, believed that species changed through heredity and over many generations.
While in this case the slippage between evolutionary theorists and their ideas is harmless, there is a long tradition of misusing Darwin’s theory of evolution through natural selection to explain and justify concepts that are not scientific but are actually actively harmful. The creation and deployment of the term “social Darwinism” is one, and the development of the pseudoscience of eugenics in the late nineteenth century is another. Eugenics took concepts rooted in Darwin’s evolutionary theory and used...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...